平台入口

陆一鸣

创建时间:  2021-12-15  孙湛蓉   浏览次数:   返回


个人介绍

        陆一鸣(男),研究员,博士生导师。国家新药审评专家,中国药学会生化与生物技术药物专业委员会、海洋药物专业委员会委员;上海市药学会生化与生物技术药物专业委员会、海洋药物专业委员会委员。主要研究领域:抗炎免疫/抗肿瘤多肽类创新药物的研究与开发;海洋生物功能分子的发现及创新药物的研究开发;药物新靶标的发现与确证;新型药物递送系统研究。建立了基于分子展示技术、AI技术和多组学技术相结合的药物先导化合物发现平台,已获3个First-in-Class 新药品种,适应症包括肿瘤、自身免疫性疾病(炎症性肠病、类风湿性关节炎)、脓毒症等。近年来主持国家自然科学基金6项,“重大新药创制”国家科技重大专项2项、国家重点研发计划1项、上海市科委支撑项目3项等各类科研项目15项。近5年发表Molecular Biology and Evolution、Journal of Medicinal Chemistry.等学术论文28篇;主编、副主编、参编专著8部;获海洋科学技术奖一等奖、上海市技术发明奖三等奖;国家发明专利18项(PCT 2项),专利转让1.09亿元等。



主要研究方向

1. 抗炎免疫/抗肿瘤多肽类药物的研究与开发

2. 海洋生物功能分子的发现及创新药物的研究开发

3. 药物新靶标的发现与确证

4、新型药物递送系统研究。



代表性学术成果

论文

1、 Yonghong Zhou#, Zhaoran Yu# , Yiming Lu* To explore the influencing factors of clinical failure of anti-tumor necrosis factor-α (TNF-α) therapy in sepsis. Life Sciences, 2025,369: 123556  doi: /10.1016/j.lfs.2025.123556

2、 Yingying Li#, Ruiwei Ye#, Haorui Dai#, Jiayi Lin , Yue Cheng , Yonghong Zhou* and Yiming Lu* Exploring TNFR1: from discovery to targetedtherapy development. Journal of Translational Medicine,2025,23:71 doi: 10.1186/ s12967-025-06122-0

3、 Linxue Li  #, Ruiwei Ye #,  Yingying Li, Hanyu Pan, Sheng Han*, Yiming Lu*. Targeting TNFR2 for cancer immunotherapy: recent advances and future directions. Journal of Translational Medicine,2024, 22:812.  doi: 10.1186/s12967-024-05620-x

4、 Ruiwei Ye  #, Hao Zheng#, Dandan Yang #, Jiayi Lin #, Linxue Li,Yingying Li, Hanyu Pan, Haorui Dai, Liang Zhao*, Yonghong Zhou*, Sheng Han*, Yiming Lu1,2 *  irAE-colitis induced by CTLA-4 and PD-1 blocking were ameliorated by TNF blocking and modulation of gut microbial. Biomedicine & Pharmacotherapy, 2024177:116999.  doi: 10.1016/j.biopha.2024.116999

5、 Yue Wang#, Ruiwei Ye#, Liming Fan#, Xin Zhao, Linxue Li, Hao Zheng , Yan Qiu*, Xiuxia He*, Yiming Lu* A TNF-α blocking peptide that reduces NF-κB and MAPK activity for attenuating inflammation. Bioorganic & Medicinal Chemistry, 2023 Jul 20;92:117420. doi: 10.1016/j.bmc.2023.117420.

6、 Sheng Han#*, Yiming Lu*. Fluorine in anti-HIV drugs approved by FDA from 1981 to 2023. European Journal of Medicinal Chemistry,2023, https://doi.org/10.1016/j.ejmech.2023.115586.

7、 Hao Zheng#, Junjie Wang#,  Hairong Fan#, Shuocun Wang, Ruiwei Ye, Linxue Li, Sheng Wang*, An Li* , Yiming Lu* Comparative venom multi-omics reveal the molecular basis and regulatory mechanisms of the diet divergence of closely related sea snakes. Molecular Biology and Evolution, 2023, 40(6) doi: /10.1093/molbev/msad125

8、 Helin Wang#, Junjie Wang#, Xin Zhao#, Ruiwei Ye, Li Sun, Jiaojiao Wang, Linxue Li, Hong Liang*, Sheng Wang*, Yiming Lu*.Discovery of an Anti-TNF-α 9-mer Peptide from a T7 Phage Display Library for the Treatment of Inflammatory Bowel Disease. Journal of Medicinal Chemistry, 2023,66(10):6981-6993. doi: 10.1021/acs.jmedchem.3c00436.

9、 Shuocun Wang #, Liming Fan #, Hanyu Pan #, Yingying Li, Xin Zhao, Yan Qiu*, Yiming Lu*.Identification and Characterization of a Novel Cathelicidin from Hydrophis cyanocinctus with Antimicrobial and Anti-Inflammatory Activity. Molecules,2023,28(5):2082. doi: 10.3390/molecules28052082

10、 Jiahao Ye #, An Li #, Hao Zheng, Banghua Yang*, Yiming Lu*. Machine Learning Advances in Predicting Peptide/Protein-Protein Interactions Based on Sequence Information for Lead Peptides Discovery. Advanced Biology. 2023:2200232, doi: 10.1002/adbi.202200232

11、 Shuocun Wang #, Liming Fan #, Hanyu Pan, Yingying Li, Yan Qiu*, Yiming Lu *.Antimicrobial peptides from marine animals: Sources, structures, mechanisms and the potential for drug development. Frontiers in Marine Science,2023, 9:1112595. doi: 10.3389/fmars.2022.1112595

12、 An Li#, Junjie Wang#, Kuo Sun#, Shuocun Wang#, Xin Zhao, Tingfang Wang, Liyan Xiong, Weiheng Xu, Lei Qiu, Yan Shang*, Runhui Liu*,  Sheng Wang*, Yiming Lu*. Two reference-quality sea snake genomes reveal their divergent evolution of adaptive traits and venom systems. Molecular Biology and Evolution, 2021,38(11):4867–4883.doi: 10.1093/molbev/msab212.

13、 An Li #, Kuo Sun#, Junjie Wang, Shuocun Wang, Xin Zhao, Runhui Liu*, YimingLu* Recombinant expression, purification and characterization of human soluble tumor necrosis factor receptor 2. Protein Expression and Purification,2021 :105857  doi: 10.1016/j.pep.2021.105857.

14、 Shanshan Guo#, Wenye Geng#, Shan Chen#, Li Wang, Xuli Rong , Shuocun Wang, Tingfang Wang, Liyan Xiong, Jinghua Huang*, Xiaobin Pang*, Yiming Lu*. Ginger alleviates DSS-induced ulcerative colitis severity by improving the diversity and function of gut microbiota. Front. Pharmacol. 2021,12:632569. DOI:10.3389/fphar.2021.632569  



参编著作

1、 《生物分子展示技术:基础与应用》,科学出版社,2022.11,主编

2、 《药学分子生物学》,中国医药科技出版社,2017,参编

3、 《疫苗工程》,华东理工大学出版社,2009,副主编

4、 《医学分子遗传学》,科学出版社,2009,副主编

5、 《医学遗传学》,科学出版社,2009,参编

6、 《染色体、基因与疾病》,科学出版社,2008,参编

7、 《现代生物工程》,科学出版社,2007,参编

8、 《遗传性非息肉病性结直肠癌》,第二军医大学出版社,2006,参编



社会学术兼职

1、国家新药审评专家

2、中国药学会生化与生物技术药物专业委员会,委员

3、中国药学会海洋药物专业委员会,委员

4、上海市药学会生化与生物技术药物专业委员会,委员

5、上海市药学会海洋药物专业委员会,委员





上一条:刘昌胜

下一条:钱其军